The evolving multi-agent options for chronic lymphocytic leukaemia treatment

Lancet Haematol. 2022 Oct;9(10):e711-e712. doi: 10.1016/S2352-3026(22)00221-6. Epub 2022 Aug 18.

Authors

Javier de la Serna¹, Tycho Baumann²

Affiliations

¹ Department of Hematology, Hospital Universitario 12 de Octubre, Universidad Complutense, 28041 Madrid, Spain. Electronic address: drjdelaserna@gmail.com.
² Department of Hematology, Hospital Universitario 12 de Octubre, Universidad Complutense, 28041 Madrid, Spain.

PMID: 35988548
DOI: 10.1016/S2352-3026(22)00221-6

No abstract available

Publication types

Comment

MeSH terms

Humans
Leukemia, Lymphocytic, Chronic, B-Cell* / drug therapy